Mucormycosis Treatment Market, By Species (Cunninghamella, Saksenaea, Rhizopus, Rhizomucor, Mucor, Lichtheimia, Apophysomyces And Others), By Diagnosis Method (Computed Tomography, Magnetic Resonance Imaging, Tissue Biopsy And Others.), By Treatment (Amphotericin B Therapy, Antifungal Medication, Surgery, And Others), By End-User, (Hospitals, Clinics, Research Organization, Medical Institute And Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Health officials in Maharashtra and Gujarat have reported an increase in cases of mucormycosis, a fungal infection that can cause blindness, severe illness, and in some cases, even death, among COVID-19 survivors. In response to an increase in cases of mucormycosis, or "black fungus" infection, the Gujarat government has begun establishing dedicated wards in hospitals for COVID-19 survivors and has acquired 5,000 vials of a medication used in its treatment. In Maharashtra, mucormycosis has caused at least eight COVID-19 survivors to lose vision in one eye, and 200 more are undergoing treatment.